AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca unveils new R&D centre in Hong Kong
AstraZeneca unveils new R&D centre in Hong Kong
The R&D centre will focus on cell and gene therapy studies.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Commentary
How Hong Kong SMEs should set boundaries for agentic AI in B2B selling
Stablecoin payments are going mainstream. Hong Kong and APAC are showing how
How commercial spaces must adapt to changing consumer expectations
AI, data centres, and the coming energy supercycle in Hong Kong